Lithium-Ion Battery Market Top Players, Segments, Cost Structure, Demand, Sales by 2027: Grand View Research Inc.

 

Lithium-ion Battery Market Growth & Trends

The global lithium-ion battery market size is expected to reach USD 87.5 billion by 2027, expanding at a CAGR of 13.0%, according to a new report by Grand View Research, Inc. Rising sales of Electric Vehicles (EVs) and variation in consumer preferences is expected to drive the market.

Improved usage of li-ion batteries in EVs, grid storage, and portable consumer electronics systems owed to its high safety level with high energy density is projected to drive market growth. These batteries are used in applications that can provide a high-energy-density solution and are lightweight. Thus, these batteries offer maximum energy density per weight and are frequently used in smartphones, computers, and HEVs.

In addition, technological advancements to decrease the weight and cost of the battery and to increase power output and efficiency are expected to enhance market expansion. Efficient distribution channels are likely to be an essential method for market players to attain a competitive advantage. The industrial application segment dominated the overall market and accounted for over 34.3% of the total revenue in 2019.

The energy storage system application segment is expected to witness an estimated CAGR of 13.8% from 2020 to 2027 owing to the advancements in solar PV and wind energy systems in countries, including China, Germany, and the United States. Asia Pacific accounted for 33.1% of the global market share in 2019. The region is likely to illustrate a substantial rise on account of the execution of government policies to promote EVs in China and India.

Encouraging incentives are taken by the government authorities, including the net metering system, have stimulated the installation of rooftop solar photovoltaic panels. Battery energy storage system is an integral part of rooftop solar panels for power generation process, as solar energy can be stored in the system can be used during the night. This, in turn, will subsequently drive the demand for lithium-ion batteries in the coming years.

Request a free sample copy or view report summary: Lithium-ion Battery Market Report

Lithium-ion Battery Market Report Highlights

• The LMO product segment was valued over USD 5.3 billion in 2019
• Asia Pacific region is projected to grow at a substantial rate throughout the forecast period. India is expected to account for the maximum market share in the Asia Pacific
• The Lithium Cobalt Oxide (LCO) segment dominated the industry and accounted for 18.2% of total market revenue in 2019
• In North America, the market is likely to display a moderate growth rate during the projected period

Access Press Release@ https://www.grandviewresearch.com/press-release/global-lithium-ion-battery-market

Lithium-ion Battery Market Segmentation

Grand View Research has segmented the global lithium-ion battery market on the basis of product, application, and region:

Lithium-ion Battery Product Outlook (Revenue, USD Billion, 2016 - 2027)

• Lithium cobalt oxide (LCO)
• Lithium iron phosphate (LFP)
• Lithium Nickel Cobalt Aluminum Oxide (NCA)
• Lithium Manganese Oxide (LMO)
• Lithium Titanate (LTO)
• Lithium Nickel Manganese Cobalt (LNMC)

Lithium-ion Battery Application Outlook (Revenue, USD Billion, 2016 - 2027)

• Consumer Electronics
• Automotive
• Energy storage system
• Industrial

Lithium-ion Battery Regional Outlook (Revenue, USD Billion, 2016 - 2027)

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • The U.K.
  • France
  • Russia
  • Spain
  • Italy
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
• Central and South America
  • Brazil
  • Colombia
  • Paraguay
• The Middle East and Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • Egypt

List of Key Players of Lithium-ion Battery Market

• GS Yuasa International Ltd.
• BYD Company Ltd.
• A123 Systems LLC
• Hitachi Chemical Co., Ltd.
• Shenzhen Huayu New Energy Technology Co., Ltd.
• Johnson Controls
• NEC Corporation, Panasonic Corporation
• Samsung SDI Co., Ltd.
• Toshiba Corporation
• LG Chem Ltd.
• Saft
• Sony Corporation
• Narada Power Source Co., Ltd.
• Contemporary Amperex Technology Co.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Industrial Refrigeration Systems Market Top Players ,Analysis And Forecast Till 2028: Grand View Research Inc.

 Industrial Refrigeration Systems Market Growth & Trends

The global industrial refrigeration systems market size is estimated to reach USD 22.65 billion by 2028, registering a CAGR of 3.9% from 2021 to 2028, according to a new report by Grand View Research, Inc. The growth of food retail chains worldwide is expected to boost the demand for industrial refrigeration systems over the forecast period. Moreover, increasing initiatives taken by governments to improve and strengthen the cold chain infrastructure are expected to drive market growth.

Rising concerns around global warming have shifted the focus of industrial refrigeration system manufacturers and users from the thermodynamic properties of refrigerants to their Ozone Depletion Potential (ODP) and Global Warming Potential (GWP). Major industrial refrigeration systems players are focused on designing environment-friendly refrigeration systems owing to various benefits they offer, such as cost-effectiveness, lower power consumption, and low toxicity. For instance, in October 2019, EVAPCO, Inc., a prominent industrial refrigeration systems manufacturer, expanded its product line of low-charge packaged ammonia chiller systems by adding the Large-Single (LS) and Large Dual (LD) models. The products feature a Small-Single (SS) capacity of 250 Tons of Refrigeration (TR) at a supply glycol of 22°F.

The rising concerns regarding the use of refrigerants with a high global warming potential are expected to encourage developments in alternative industrial refrigeration systems. Magnetic refrigeration is another emerging technology that does not use a refrigerant but a heating or cooling liquid, is often water-based and has higher energy efficiency.

The shutdown of manufacturing and transportation facilities and food production units to prevent the spread of Covid-19 has resulted in a decline in the sales of industrial refrigeration systems. However, the increased deployment of cold chains to store and preserve vaccines and refrigerated transportation systems for facilitating its reach in large quantities is anticipated to continue supporting the market growth.

Request a free sample copy or view report summary: Industrial Refrigeration Systems Market Report

Industrial Refrigeration Systems Market Report Highlights

• The food and beverage segment accounted for the highest revenue share of over 55.0% of the overall market in 2020. The segment growth can be attributed to the rising disposable income and increased demand for packaged and processed food by consumers
• The compressors segment is anticipated to witness the highest CAGR of around 5.0% over the forecast period. The growth can be attributed to the availability of natural refrigerants, which help compressors in increasing the cooling capacity and reduce the contribution to global warming
• The Asia Pacific market is expected to witness the fastest growth, accounting for a CAGR of over 5.0% from 2021 to 2028. The rising adoption of cold chain infrastructure is expected to drive market growth in the region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-industrial-refrigeration-systems-market

Industrial Refrigeration Systems Market Segmentation

Grand View Research has segmented the global industrial refrigeration systems market based on component, capacity, application, and region:

Industrial Refrigeration Systems Component Outlook (Revenue, USD Billion, 2018 - 2028)

• Compressors
  • Rotary Screw Compressors
  • Centrifugal Compressors
  • Reciprocating Compressors
  • Other Compressors
• Condensers
• Evaporators
• Controls
• Others

Industrial Refrigeration Systems Capacity Outlook (Revenue, USD Billion, 2018 - 2028)

• Less than 100 kW
• 100-500 kW
• 500kW-1,000kW
• 1,000kW-5,000kW
• More than 5,000 kW

Industrial Refrigeration Systems Application Outlook (Revenue, USD Billion, 2018 - 2028)

• Refrigerated Warehouse
• Food & Beverage
• Chemical, Petrochemical, & Pharmaceutical
• Refrigerated Transportation

Industrial Refrigeration Systems Regional Outlook (Revenue, USD Billion, 2018 - 2028)

• North America
  • US
  • Canada
• Europe
  • Germany
  • UK.
  • France
• Asia Pacific
  • China
  • India
  • Japan
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa

List of Key Players in the Industrial Refrigeration Systems Market

• Johnson Controls
• Emerson Electric Co.
• Danfoss
• GEA Group Aktiengesellschaft
• MAYEKAWA MFG. CO., LTD.
• BITZER Kühlmaschinenbau GmbH
• DAIKIN INDUSTRIES, Ltd.
• EVAPCO, Inc.
• Güntner GmbH & Co. KG
• LU-VE S.p.A.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Cancer Biopsy Market Expected to Receive Greater Traction As Manufacturers’ Contribution Swells

 Cancer Biopsy Market Growth & Trends

The global cancer biopsy market size is expected to reach USD 44.51 billion by 2027, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 11.13% from 2021 to 2027. The expanding landscape of molecular medicine paved the way for the development of new devices for the molecular characterization of cancers. Thus, increasing adoption and product approvals for liquid biopsies are expected to drive the overall market.

The kits and consumables product segment is expected to maintain its lead in the years to come. Acknowledging this trend, various market players have invested in the development of novel kits in order to expand their biopsy kits portfolio. For instance, in April 2021, Sysmex Europe GmbH, along with Sysmex Inostics GmbH, introduced Plasma-SeqSensei liquid biopsy research use only (RUO) kits in EMEA.

The tissue biopsies segment emerged as the dominant type segment in 2020. Shortcomings of liquid biopsies such as the lack of robust efficacy evaluations and associated high costs are currently bridged by tissue biopsies. This has made tissue biopsy a gold-standard procedure in the present diagnostic scenario.

Liquid biopsies are expected to offer lucrative opportunities in the field of oncology-based personalized medicine and genomic data analysis. Recognizing the potential of these tests, the regulatory bodies are actively supporting the commercialization of these products and increasing the use of these assays in clinics. For instance, in November 2020, the FoundationOne Liquid CDx test was approved by the U.S. FDA as a companion diagnostic device for multiple cancers.

The liquid biopsies segment is expected to expand at an exponential rate in the coming years, wherein increasing investments and strategic initiatives by companies involved in biopharmaceutical manufacturing and genomic data analysis are expected to play a central role. The emerging companies are inclined towards collaborating with well-established industry participants, including SOPHiA Genetics, QIAGEN Bioinformatics, Agilent Technologies, and Fabric Genomics. This trend is further expected to favor the overall market growth.

Key players are focusing on developing novel biopsy platforms, set to achieve business expansion, further contributing to the revenue generation in the market. In March 2021, Quick-Core Auto Biopsy System for biopsy procedure soft tissue biopsy was launched by IZI Medical Products. This product is fully automated, which is built based on the company’s proprietary semi-automatic system, Quick-Core.

Request a free sample copy or view report summary: Cancer Biopsy Market Report

Cancer Biopsy Market Report Highlights

• By product, kits and consumables accounted for the largest revenue share in 2020 and are anticipated to maintain its lead throughout the forecast period. The adoption of kits and consumables is expected to increase owing to the significant transition from tumor to liquid biopsy
• Based on type, tissue biopsies are still considered to be a mainstay of biopsies and are largely adopted across various diagnosis applications. Additionally, tumor biopsy is most adopted for diagnosis on individual levels, along with monitoring the effects of an ongoing oncology treatment
• North America held the largest revenue share in 2020 owing to the concentrated pool of active organizations and cancer foundations. The strong network of government organizations and private cancer foundations in the U.S. has made significant contributions to the regional revenue generation capacity
• In terms of application, breast cancer dominated the global market in 2020 and is expected to maintain its lead throughout the forecast period. Open surgical biopsy is considered to be a reference standard for the evaluation of patients with a suspicious breast lesion. This is attributed to its proven accuracy in diagnosing breast lesions, further contributing to the revenue generated by this segment

Access Press Release@ https://www.grandviewresearch.com/press-release/global-cancer-biopsy-market

Cancer Biopsy Market Segmentation

Grand View Research has segmented the global cancer biopsy market on the basis of product, type, application, and region:

Cancer Biopsy Product Outlook (Revenue, USD Million, 2018 - 2027)

• Instruments
• Kits and Consumables
• Services

Cancer Biopsy Type Outlook (Revenue, USD Million, 2018 - 2027)

• Tissue Biopsies
  • Needle Biopsies
    • Fine Needle Aspiration (FNA)
    • Core Needle Biopsy (CNB)
  • Surgical Biopsies
• Liquid Biopsies
• Others

Cancer Biopsy Application Outlook (Revenue, USD Million, 2018 - 2027)

• Breast Cancer
• Colorectal Cancer
• Cervical Cancers
• Lung Cancers
• Prostate Cancers
• Skin Cancers
• Blood Cancers
• Kidney Cancers
• Liver Cancers
• Pancreatic Cancers
• Ovarian Cancers
• Others

Cancer Biopsy Regional Outlook (Revenue, USD Million, 2018 - 2027)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Spain
  • Italy
• Asia Pacific
  • Japan
  • China
  • India
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia

List of Key Players of Cancer Biopsy Market

• Qiagen N.V.
• Illumina, Inc.
• ANGLE Plc
• BD (Becton, Dickinson And Company)
• Myriad Genetics
• Hologic, Inc.
• Biocept, Inc.
• Thermo Fisher Scientific, Inc.
• Danaher
• Hoffmann-La Roche Ltd.
• Lucence Diagnostics Pte. Ltd.
• GRAIL, Inc.
• Guardant Health
• Exact Sciences Corporation
• Freenome Holdings, Inc.
• Biodesix (Integrated Diagnostics)
• Oncimmune
• Epigenomics AG
• HelioHealth (Laboratory for Advanced Medicine)
• Genesystems, Inc. (Genesys Biolabs)
• Chronix Biomedical, Inc.
• Personal Genome Diagnostics Inc.
• Natera, Inc.
• Personalis Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Pharmacovigilance Market Growth in the Coming Years

 Pharmacovigilance Market Growth & Trends

The global pharmacovigilance market size is expected to reach USD 14.95 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 11.5% from 2021 to 2028. The increasing incidence of Adverse Drug Reactions (ADR) is the key growth factor. ADR imposes a substantial burden on healthcare systems and is one of the prominent causes of morbidity in developed countries. According to the National Center for Biotechnology Information (NCBI), approximately 5% of total hospitalizations in Europe each year are due to ADR. Pharmacovigilance services play an integral role in this clinical trial phase by assisting manufacturers in identifying adverse effects associated with the drug.

According to the World Health Organization's (WHO) report on pharmaceutical consumption, medicines to treat chronic diseases accounted for a larger proportion of the total volume of drug consumption in non-hospital setups. Hence, there has been a significant rise in the number of medicines made available to healthcare consumers. The rising demand for drugs has significantly heightened the need for the development of novel therapeutics via extensive clinical trials, which is expected to serve this market with lucrative opportunities.

Moreover, leading pharma companies in developed countries are focusing on outsourcing PV services to reduce costs and minimize operational expenses. This is anticipated to serve as an opportunity for contact research organizations in developing regions to gain more revenue share. Manufacturers are now focusing on remodeling their product development processes in an attempt to cater to patient needs across the globe. These factors are anticipated to fuel the demand for pharmacovigilance services during the forecast period.

Industry participants are focusing on increasing R&D activities to develop better pharmacovigilance services. Companies are also adopting strategies including new product launches and mergers & acquisitions to gain a competitive advantage. Moreover, they are undertaking collaborations with the PV service providers to gain access to medical information and manage PV workflows. For instance, in September 2019, Accenture collaborated with Bayer to implement the company's INTIENT Clinical platform to simplify and speed up its drug development processes, thereby widening its business. The company collaborated with BioCelebrate in 2017 to develop a platform for aggregating and analyzing clinical information for improved drug development efficiency, thus enhancing its R&D capabilities. Such initiatives help companies maintain their market position.

Request a free sample copy or view report summary: Pharmacovigilance Market Report

Pharmacovigilance Market Report Highlights

• By product life cycle, phase IV held a dominant share of 75.61% in 2020 owing to the extensive post-marketing surveillance of pharmaceuticals and an increasing number of ADR incidences in the market
• In terms of service provider, contract outsourcing held a significant share of 59.24% as of 2020 owing to the shift in the focus of pharmaceutical companies to outsourcing services to reduce operational cost
• Based on type, spontaneous reporting held the largest revenue share in 2020 due to its wide application in pharmacovigilance and benefits such as easy simulation of data sets for better drug comparison
• On the basis of end-use, the biotechnology companies segment is anticipated to exhibit a lucrative CAGR of 12.6% over the forecast period owing to the increasing R&D for the development of novel biologics
• Asia Pacific is anticipated to exhibit a lucrative CAGR of 13.2% in the forthcoming years. This is attributed to the availability of low-cost labor and the rising number of outsourcing companies in this region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-pharmacovigilance-market

Pharmacovigilance Market Segmentation

Grand View Research has segmented the global pharmacovigilance market on the basis of the service provider, product life cycle, type, process flow, therapeutic area, end-use, and region:

Pharmacovigilance Service Provider Outlook (Revenue, USD Million, 2016 - 2028)

• In-house
• Contract Outsourcing

Pharmacovigilance Product Life Cycle Outlook (Revenue, USD Million, 2016 - 2028)

• Pre-clinical
• Phase I
• Phase II
• Phase III
• Phase IV

Pharmacovigilance Type Outlook (Revenue, USD Million, 2016 - 2028)

• Spontaneous Reporting
• Intensified ADR Reporting
• Targeted Spontaneous Reporting
• Cohort Event Monitoring
• EHR Mining

Pharmacovigilance Process Flow Outlook (Revenue, USD Million, 2016 - 2028)

• Case Data Management
  • Case Logging
  • Case Data Analysis
  • Medical Reviewing & Reporting
• Signal Detection
  • Adverse Event Logging
  • Adverse Event Analysis
  • Adverse Event Review & Reporting
• Risk Management System
  • Risk Evaluation System
  • Risk Mitigation System

Pharmacovigilance Therapeutic Area Outlook (Revenue, USD Million, 2016 - 2028)

• Oncology
• Neurology
• Cardiology
• Respiratory Systems
• Others

Pharmacovigilance End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Pharmaceuticals
• Biotechnology Companies
• Medical Device Manufacturers
• Others

Pharmacovigilance Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East and Africa
  • South Africa
  • Kingdom of Saudi Arabia

List of Key Players of Pharmacovigilance Market

• Accenture
• Linical Accelovance
• IQVIA
• Cognizant
• Laboratory Corporation of America Holdings
• IBM Corporation
• ArisGlobal
• ICON Plc.
• Capgemini
• ITClinical
• TAKE Solutions
• PAREXEL International Corporation
• BioClinica, Inc.
• Wipro Limited
• UNITED BIOSOURCE CORPORATION
• FMD K&L

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Antibody Drug Conjugate Market Value Expected To Increase at a CAGR of 23.7% from 2021 to 2028: Grand View Research Inc.

 

Antibody Drug Conjugate Market Growth & Trends

The global antibody drug conjugate market size is expected to reach USD 23.9 billion by 2028, according to a new report by Grand View Research Inc. The market is expected to grow at a CAGR of 23.7% from 2021 to 2028. Increasing investment in R&D and advancements in linker technology are expected to boost the growth of the antibody drug conjugates (ADCs) market.

Antibody-drug conjugates are a novel category of drugs composed of an antibody linked to a cytotoxic drug with a linker. Conventional chemotherapy is intended to kill fast-growing tumor cells. However, it can also damage healthy proliferating cells, which may produce undesirable effects. In contrast, ADCs are designed to increase the efficacy of treatment and decrease the systemic toxicity of chemotherapy drugs. Major players are entering into partnerships for the development & commercialization of these products. For instance, in July 2020, AstraZeneca collaborated with Daiichi Sankyo to develop and commercialize its new ADC candidate, DS-1062, which is in phase 1 trials for triple-negative breast cancer and Non-Small Cell Lung Cancer (NSCLC).

One of the major factors responsible for the growth of the ADCs market is the rising incidence and prevalence of cancer coupled with the growing geriatric population. According to the Cancer Research U.K., during 2015-2017, on average, nearly 36% of new cases were reported among people aged 75 years & above, each year. It is further estimated that by 2035, almost 46% of all cancer cases will be among people in the age group of 75 years & above. Moreover, the rise in the prevalence of cancer in emerging countries further boosts growth. According to Globocan, in 2020, approximately 49.2% of global cancer cases were registered in Asia. Thus, this region remains a major untapped market for ADCs.

ADCs manufacturing is a complicated and expensive process, which requires high capital investment and trained operators, stringent GMP, and high operational difficulties. Challenges in downstream processing of ADCs might restrict the market growth. These include handling MAb-linker-drug binding chemistries, balancing & combining optimal MAb specificity, preventing premature toxin release, and controlling the release of intracellular toxin. Furthermore, the lack of availability of reimbursement policies in developing economies is expected to restrict market growth.

Mergers and acquisitions are one of the key strategies employed by key players to increase their market share. For instance, in December 2020, Boehringer Ingelheim acquired NBE-Therapeutics for USD 1.44 billion. NBE-Therapeutics’ expertise in proprietary platforms for ADC development is expected to help Boehringer Ingelheim in the development of ADC drugs.

Request a free sample copy or view report summary: Antibody Drug Conjugate Market Report

Antibody Drug Conjugate Market Report Highlights

• Breast cancer was the largest revenue-generating segment in 2020 due to a high number of approved ADC products, approval of Kadcyla for early-stage breast cancer, and a high target patient population
• The cleavable linker segment dominated the market in 2020 due to its wide adoption in ADC’s product development
• Most of the pipeline and commercially available ADCs are based on cleavable linker technology
• Asia Pacific is expected to witness the fastest CAGR over the forecast period
• This growth can be credited to the increasing investments in R&D by local players and the rising geriatric population in the region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-antibody-drug-conjugates-market

Antibody Drug Conjugate Market Segmentation

Grand View Research has segmented the global antibody drug conjugate market on the basis of application, technology, and region:

ADCs Application Outlook (Revenue, USD Million, 2017 - 2028)

• Blood Cancer
  • Leukemia
  • Multiple Myeloma
  • Lymphoma
• Breast Cancer
• Urothelial Cancer & Bladder Cancer
• Others

ADCs TechnologyOutlook (Revenue, USD Million, 2017 - 2028)

• Cleavable Linker
• Non-cleavable Linker
• Linkerless

ADCs Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • Italy
  • Spain
  • France
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Antibody Drug Conjugate Market

• Takeda Pharmaceutical Company Ltd.
• Hoffmann-La Roche Ltd.
• Pfizer, Inc.
• AstraZeneca
• Gilead Sciences, Inc.
• Astellas Pharma
• Seagen, Inc.
• Daiichi Sankyo Company Ltd.
• GlaxoSmithKline Plc
• ADC Therapeutics

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Global Demand for Clinical Trial Supplies Market to Incur Considerable Upsurge During 2021 – 2028: Grand View Research Inc.

 Clinical Trial Supplies Market Growth & Trends

The global clinical trial supplies market is expected to reach USD 2.9 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to witness growth at 6.0% CAGR owing to the Increasing volume of clinical trial studies coupled with the growing complexity in conduction of these trials are the primary driver of the industry. Furthermore, geographic expansion and development of Information Technology (IT) to facilitate higher integration and smooth performance of activities are other vitally impacting parameters. Over the next eight years, the clinical trials and pharmaceutical industry is anticipated to continue steady growth, thereby promoting the high requirement of clinical trial supplies.

U.S and Canada are home to majority of clinical trials which are conducted in this region. No language barrier is one of the major factors for the preference of this region for majority of clinical trials, as English language is widely spoken in this region. Major CRO’s and biopharmaceutical companies have their hub in this region and with advancement in technology the demand for efficient supplies is increasing and the region is expected to dominate the clinical trial supplies market over the forecast period.

Request a free sample copy or view report summary: Clinical Trial Supplies Market Report

Clinical Trial Supplies Market Report Highlights

• On the basis of clinical phase, the market is anticipated to be dominated by Phase III in 2025. The presence of large number of molecules estimated to reach Phase III by 2020 is the primary factor responsible for this prediction.
• By services, storage and distribution is anticipated to witness the fastest growth at a CAGR of over 7.0%.
• Key end-users of this industry are pharmaceuticals, and biologics. Biologics are expected to witness fastest growth owing to the increasing research in the field of genetics and biotechnology such as development of nanoparticle-based drug delivery systems.
• In terms of therapeutic use or clinical indication, oncology dominates the market. The highest research activity as of 2016 is being performed for this indication, which in turn is expected to drive the market.
• Few of the industry players include Movianto GmbH, Thermo Fischer Scientific, Sharp Packaging Services, Catalent Pharma Solution, Biocair International Ltd., PCI Services, Almac Group Ltd, and Patheon Inc. Other players present in the market space include Clinigen Group Plc, Merck Serono, and Chimerix.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-clinical-trial-supplies-market

Clinical Trial Supplies Market Segmentation

Grand View Research has segmented the global clinical trial supplies market on the basis of clinical phase, product and services, therapeutic use, end-use, and region:

Clinical Trial Supplies Clinical Phase Outlook (Revenue, USD Million, 2016 - 2028)

• Phase I
• Phase II
• Phase III
• Other

Clinical Trial Supplies Product & Services Outlook (Revenue, USD Million, 2016 - 2028)

• Manufacturing
• Storage & Distribution
  • Cold Chain Distribution
  • Non-cold Chain Distribution
• Supply Chain Management

Clinical Trial Supplies End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Pharmaceutical
• Biologics
• Medical device
• Others

Clinical Trial Supplies Therapeutic Use Outlook (Revenue, USD Million, 2016 - 2028)

• Oncology
• CNS Disorders
• Cardiovascular
• Infectious Disease
• Metabolic Disorders
• Others

Clinical Trial Supplies Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
• Asia Pacific
  • China
  • Japan
• Latin America
  • Mexico
  • Brazil
• MEA
  • South Africa
  • Saudi Arabia

List of Key Players of Clinical Trial Supplies Market

• Almac Group
• Biocair
• Catalent, Inc.
• KLIFO
• Movianto (Walden Group)
• PCI Pharma Services
• Sharp
• Thermo Fischer Scientific, Inc.
• Marken
• Parexel International Corporation

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

China Testing, Inspection, And Certification Market Growth in the Coming Years

 China Testing, Inspection, And Certification Market Growth & Trends

The China testing, inspection, and certification market size is anticipated to reach USD 64.9 billion by 2028, according to a new report by Grand View Research. The market is anticipated to expand at a CAGR of 7.1% from 2021 to 2028. The high standards of living of Chinese citizens and increased focus of customers on quality and safety of food products and consumer goods such as toys, personal care & beauty products, and electrical and electronic appliances are driving the growth of the China testing, inspection, and certification (TIC) market. Furthermore, an increase in outsourcing of testing, inspection, and certification services by prominent companies operating in the manufacturing, automotive, and consumer goods application areas is projected to boost the growth of the market in China.

Furthermore, the TIC market is expected to grow at a faster pace in China owing to government investments in the transportation and energy sectors as well as the construction industry. The Chinese government has introduced favorable policies for international players to establish their foothold in the country to achieve progressive liberalization. The domestic players capture a majority share of the market in several Chinese provinces. The government has encouraged foreign investments by lifting the barriers for international TIC providers to enter and operate in the Mainland marketplace.

Previously, most companies in China conducted their testing, inspection, and certification operations in-house. However, with the growing acceptance of the China Compulsory Certification (CCC), a greater emphasis is placed on the need for strict regulatory standards and certifications and this has led to an increase in outsourcing activities of TIC in China due to cost benefits. This growing trend of outsourcing TIC services is anticipated to further drive the growth of the market over the forecast period due to the increased accessibility of the domestic market for international players and the provision of cost-effective solutions by the TIC service providers.

Request a free sample copy or view report summary: China Testing, Inspection, And Certification Market Report

China Testing, Inspection, And Certification Market Report Highlights

• The Chinese TIC market is witnessing considerable growth owing to an increasing number of investments from international incumbents
• The inspection service segment is expected to expand at the highest CAGR of 8.1% over the forecast period
• TIC forms an integral part of the infrastructure and transportation sectors in China and hence, the growth of the two sectors is expected to drive the demand for testing inspection, and certification activities

Access Press Release@ https://www.grandviewresearch.com/press-release/china-testing-inspection-certification-tic-market-analysis

China Testing, Inspection, And Certification Market Segmentation

Grand View Research has segmented the China testing, inspection, and certification market based on service, sourcing type, and application:

China TIC Service Outlook (Revenue, USD Billion, 2018 - 2028)

• Testing
• Inspection
• Certification

China TIC Sourcing Type Outlook (Revenue, USD Billion, 2018 - 2028)

• In-house
• Outsourced

China TIC Application Outlook (Revenue, USD Billion, 2018 - 2028)

• Consumer Goods & Retail
  • Personal Care & Beauty Products
  • Hard Goods
  • Soft-liners & Accessories
  • Toys & Juvenile Products
  • Electrical & Electronics
  • Others (Detergents and Non-woven products)
• Agriculture & Food
  • Seed & Crop
  • Fertilizers
  • Commodities
  • Beverages
    • Alcoholic
      • Beer
      • Spirits
      • Wine
      • Others (Cider and Cocktails)
    • Non-alcoholic
      • Carbonated soft drinks
      • Fruit drinks
      • Bottled water
      • Functional beverages
      • Sports drinks
      • Others (Milk-based drinks)
    • Others (Forestry and Food packaging)
  • Chemicals
    • Asset Integrity Management Services
    • Project Life Cycle Services
    • Finished Product Services
    • Chemical Feedstocks Services
    • Others (Lab design and Operation & Commissioning)
  • Infrastructure
    • Project Management
    • Material Services
    • Construction Machinery & Equipment Services
    • Facilities Management & Inspection Services
    • Others (Supply Chain Services and Quality Health & Safety)
  • Energy & Power
    • Energy sources
      • Nuclear
      • Wind
      • Solar
      • Alternative fuels
      • Fuel Oil & Gases
      • Coal
      • Hydropower
      • Others (Geothermal energy, Tidal energy)
    • Power generation
    • Power Distribution
    • Asset Integrity Management Services
    • Project Life Cycle Services
    • Others (Technical Staffing and Quality & Safety)
  • Manufacturing
    • Suppliers Related Services
    • Production & Products Related Services
    • Projects Related Services
    • Others (Logistics and Safety)
  • Healthcare
    • Medical Devices
    • Health, Beauty, and Wellness
    • Clinical Services
    • Laboratory Services
    • Biopharmaceutical & Pharmaceutical Services
    • Others (Training and Staffing)
  • Mining
    • Inspection & Sampling Service
    • Analytical Service
    • Exploration Service
    • Metallurgy & Process Design
    • Production & Plant Services
    • Project Risk Assessment & Mitigation
  • Oil & Gas and Petroleum
    • Upstream
    • Midstream
    • Downstream
    • Biofuels & Feedstock
    • Petrochemicals
    • Asset Integrity Management Services
    • Project Life Cycle Services
    • Others (Functional safety services)
  • Public Sector
    • Product Conformity Assessment
    • Monitoring Services
    • Valuation Services
    • Others (Road Safety Traffic, E-government, and Technical Verification Programs)
  • Transportation
    • Automotive
      • Electrical Systems & Components
      • Electric Vehicles, Hybrid Electric Vehicles, and Battery Systems
      • Telematics
      • Fuels, Fluids, and Lubricants
      • Interior and Exterior Materials and Components
      • Vehicle Inspection Services (VIS)
      • Homologation Testing
      • Others (Aftermarket distribution)
    • Aerospace & Defense
      • Services for Airports
      • Services for Aviation
      • Services for Aerospace
    • Marine
      • Marine Fuel Systems & Component Services
      • Ship Classification Services
      • Marine Materials & Equipment Services
      • Others (Cargo, Crane, and Vessel)
    • Rail
      • Rail Testing Services
      • Rail Inspection Services
      • Rail Certification Services
      • Others (Lab Testing and Supplier Accreditation)
    • Supply Chain & Logistics
      • Packaging & Handling
      • Risk Management
      • Others (Audits, Certification, and Training)
    • Others

List of Key Players in the China Testing, Inspection, And Certification Market

• AsureQuality Limited
• Bureau Veritas SA
• DEKRA SE
• DNV GL Group AS
• Intertek Group PLC
• Lloyd’s Register Group Limited
• SGS S.A
• TUV Rheinland AG Group
• Underwriters Laboratories Inc.
• Asia Quality Focus
• HQTS Group Ltd.
• InTouch Services Ltd.
• China Inspection Co., Ltd.
• Centre Testing International
• China Certification & Inspection Group
• Asia Quality Control
• V-Trust
• TUV SUD
• TUV Nord
• American Bureau of Shipping
• Hartford Steam Boiler
• Larsen & Toubro
• Asia Inspection
• China Building Material Test & Certification Group Co. Ltd.
• China Special Equipment Inspection and Research Institute
• China Classification Society

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Adhesives And Sealants Market Booming Trends and Forecast Assessment for the Period 2021 to 2028

 Adhesives & Sealants Market Growth & Trends

The global adhesives and sealants market size is expected to reach USD 95.41 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.0% from 2021 to 2028. Rising investments in construction and infrastructure are projected to play a key role in the expansion of the market.

The positive outlook of infrastructure projects across Asia, the U.S., the Middle East, and Eastern Europe is likely to fuel the demand for adhesives and sealants over the coming years. With environmental regulations forcing industry participants to adopt eco-friendly products, water-based and non-solvent products are projected to gain greater prominence in the market in the near future.

Increasing infrastructure spending across the residential and commercial sectors worldwide is propelling the installation of different types of flooring such as resilient and wooden, which, in turn, is fueling the consumption of adhesives and sealants. The rising need for residential space on account of the increasing population as well as rising standard of living is leading toward the growth of the global industry.

The adoption of adhesive products is substituting the usage of mechanical fasteners in the industries such as automotive, aerospace, and packaging. The use of such products instead of conventional equipment offers a reduction in the final weight of the product, which has become a key focus area in the automotive and aerospace industries over the last half a decade. Most formulators in the packaging industry also rely on adhesives rather than heavy bolting techniques to minimize their freight charges.

The major demand arises across multiple application scopes as buyers from diverse fields demand high-quality, sustainable, and eco-friendly products. The demand is high for adhesives and sealants, which have lower levels of Volatile Organic Compounds (VOCs), give out fewer emissions, and provide aesthetic bonding solutions across numerous substrates, simultaneously meeting the international and regional government regulations. Water-based products are considered environment-friendly since they contain zero VOCs. They also provide good long-term high temperature and moisture resistance.

Request a free sample copy or view report summary: Adhesives And Sealants Market Report

Adhesives And Sealants Market Report Highlights

• Adhesives accounted for the largest revenue share of over 85.0% in 2020. The market is projected to grow on account of the rising construction spending around the world owing to the growing demand in applications such as flooring, carpet laying, countertop lamination, and drywall lamination
• In terms of volume, Asia Pacific was the largest regional market in 2020 and is anticipated to maintain its lead over the forecast period. The growth of the regional market is primarily attributed to the expansion of the industrial sectors in countries such as China, India, South Korea, Indonesia, and Singapore
• The paper and packaging application segment accounted for a revenue share of over 25.0% in 2020 in the adhesives market. Rising demand for flexible packaging for the end-use industries, such as food and beverage and consumer, is projected to benefit the expansion of the segment
• In the adhesives market, the water-based technology segment is projected to expand on account of the excellent joining quality, fast set speed, and a reduction in the usage of solvent-based technology formulations. This segment is likely to expand at a lucrative CAGR of 6.6% from 2021 to 2028, in terms of revenue

Access Press Release@ https://www.grandviewresearch.com/press-release/global-adhesives-and-sealants-market

Adhesives & Sealants Market Segmentation

Grand View Research has segmented the global adhesives market on the basis of technology, product, application, and region; and segmented the global sealants market on the basis of product, application, and region:

Adhesives Technology Outlook (Volume, Kilotons; Revenue, USD Million, 2017 - 2028)

• Water Based
• Solvent Based
• Hot Melt
• Reactive & Others

Adhesives Product Outlook (Volume, Kilotons; Revenue, USD Million, 2017 - 2028)

• Acrylic
• PVA
• Polyurethanes
• Styrenic Block
• Epoxy
• EVA
• Others

Adhesives Application Outlook (Volume, Kilotons; Revenue, USD Million, 2017 - 2028)

• Paper & Packaging
• Consumer & DIY
• Building & Construction
• Furniture & Woodworking
• Footwear & Leather
• Automotive & Transportation
• Medical
• Others

Adhesives Regional Outlook (Volume, Kilotons; Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
• Central & South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • GCC

Sealants Product Outlook (Volume, Kilotons; Revenue, USD Million, 2017 - 2028)

• Silicones
• Polyurethanes
• Acrylic
• Polyvinyl Acetate
• Others

Sealants Application Outlook (Volume, Kilotons; Revenue, USD Million, 2017 - 2028)

• Construction
• Automotive
• Packaging
• Assembly
• Consumers
• Others

Sealants Regional Outlook (Volume, Kilotons; Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
• Central & South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • GCC

List of Key Players of Adhesives & Sealants Market

• 3M Company
• Ashland Inc.
• Avery Denison Corporation
• H B Fuller
• Henkel AG
• Sika AG
• Pidilite Industries
• Huntsman
• Wacker Chemie AG
• RPM International Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Impact of Existing and Emerging Botanical Ingredients Market Trends And Forecast 2020-2028: Grand View Research Inc.

 Botanical Ingredients Market Growth & Trends

The global botanical ingredients market size is expected to reach USD 246.59 billion by 2028, according to a new report by Grand View Research, Inc., expanding at a CAGR of 6.9% over the forecast period. The market is expected to be driven by the increasing demand for convenience and functional food products coupled with the advent of clean and natural botanical supplements by key market participants. The food and beverages industry has been one of the biggest application areas for botanical ingredients. They are widely used in various foods & beverages, such as bakery&dairy products, energy drinks, and confectionery products, owing to their unique flavor and health benefits.

Health-conscious consumers prefer food products with high nutritive content. The outbreak of COVID-19 has also shifted customer focus towards preventive healthcare with an emphasis on natural and clean products. Thus, food & beverage manufacturers are focusing on fortifying food products with flavorful and nutritive plant-based ingredients, such as tea extracts. Botanical ingredients are sourced from herbs, leaves, spices, flowers, etc. Spices accounted for the highest revenue share in 2020. The increasing trend of experiencing novel food, high usage as a natural ingredient in cosmetic products, and increasing awareness about health benefits associated with it are major factors contributing towards the high market share.

The rising demand for health beneficial products and the introduction of novel food products by the processed food companies to expand product range and differentiate from competitors are factors expected to boost the market growth. The powder form accounted for the largest market share in 2020. This is due to its high amounts of active ingredients, longer shelf life compared to liquid form, and extensive utilization in various applications, such as bakery, confectionery, sauces, dressings, meat, soy, dairy, dietary supplements, and medicines. Moreover, powder form is less likely to be contaminated owing to its concentrated nature.

Asia Pacific has been experiencing a high growth over the past few years and the trend is expected to continue over the forecast period. In the Asia Pacific region, developing countries, such as China and India, have witnessed an exponential growth in the consumption of functional foods and dietary supplements in the last 10 years. The nutraceuticals industry in developed economies, such as Japan, Australia, and South Korea, has shown an upward growth trajectory in the recent past. As a result, Asia Pacific has emerged as a budding market for botanical ingredients, supported by health and wellness trends across various countries.

Request a free sample copy or view report summary: Botanical Ingredients Market Report

Botanical Ingredients Market Report Highlights

• The spice source segment accounted for the largest volume as well as the revenue share of the global market in 2020
• It is expected to witness substantial gains over the forecast period due to the high demand for health beneficial ingredients and manufacturers effort in offering novel products
• North America dominated the market in 2020, in terms of revenue, due to the well-established dietary supplements market
• Favorable economic policies for advancements in the healthcare industry and consistent demand for novel products are expected to drive the regional market
• The food & beverage application segment held the largest value share in 2020 and is expected to witness steady growth in the coming years
• This growth is mainly due to the growing consumption of packaged foods as a result of rapid urbanization and changing lifestyles
• Key players are increasingly consolidating their position in the market mainly by acquiring small-sized firms
• Companies are also focusing on offering tailored products wherein the content or composition of extracts and concentrate is customized

Access Press Release@ https://www.grandviewresearch.com/press-release/global-botanical-ingredients-market

Botanical Ingredients Market Segmentation

Grand View Research has segmented the global botanical ingredients market on the basis of source, form, application, and region:

Botanical Ingredients Source Outlook (Volume, Kilo Tons; Revenue, USD Thousand, 2017 - 2028)

• Herbs
• Leaves
• Spices
• Flowers
• Others

Botanical Ingredients Form Outlook (Volume, Kilo Tons; Revenue, USD Thousand, 2017 - 2028)

• Powder
• Liquid

Botanical Ingredients Application Outlook (Volume, Kilo Tons; Revenue, USD Thousand, 2017 - 2028)

• Food & Beverages
  • Food
    • Bakery & Confectionery
    • Sauces & Dressings
    • Others
  • Beverages
    • Energy Drinks
    • Sports Drinks
    • Functional Juices
    • Others
  • Dietary Supplements
  • Personal Care& Cosmetics
  • Pharmaceuticals
  • Others

Botanical Ingredients Regional Outlook (Volume, Kilo Tons; Revenue, USD Thousand, 2017 - 2028)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK.
  • France
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
• Central & South America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa

List of Key Players of Botanical Ingredients Market

• Indesso
• Lipoid Kosmetic AG
• The Herbarie at Stoney Hill Farm, Inc.
• International Flavors& Fragrances, Inc.
• Bell Flavors& Fragrances
• Rutland Biodynamics Ltd.
• Prakruti Products Pvt. Ltd.
• Ltd.
• The Green Labs LLC
• Berje, Inc.
• Umalaxmi Organics Pvt. Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.